We are live on ! Find out more
MGNX icon

MacroGenics

113 hedge funds and large institutions have $583M invested in MacroGenics in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 29

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

37% more call options, than puts

Call options by funds: $824K | Put options by funds: $600K

6% more capital invested

Capital invested by funds: $548M → $583M (+$34.7M)

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

0% more funds holding

Funds holding: 113113 (0)

3.66% less ownership

Funds ownership: 89.48%85.82% (-3.7%)

Holders
113
Holders Change
Holders Change %
0%
% of All Funds
2.82%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
12
Increased
48
Reduced
29
Closed
11
Calls
$824K
Puts
$600K
Net Calls
+$224K
Net Calls Change
+$479K
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$1M -$82K -4,736 -8%
Allianz Asset Management
52
Allianz Asset Management
Germany
$961K +$676 +39 +0.1%
Macquarie Group
53
Macquarie Group
Australia
$924K
Ohio Public Employees Retirement System (OPERS)
54
Ohio Public Employees Retirement System (OPERS)
Ohio
$882K
CS
55
Credit Suisse
Switzerland
$849K +$327K +18,892 +70%
AllianceBernstein
56
AllianceBernstein
Tennessee
$795K
GPCM
57
Granite Point Capital Management
Massachusetts
$756K +$708K +40,900 New
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$748K +$6.84K +395 +1%
AA
59
ALPS Advisors
Colorado
$670K +$80.3K +4,635 +15%
ARTA
60
A.R.T. Advisors
New York
$631K +$592K +34,193 New
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
$625K
CCMH
62
Cornerstone Capital Management Holdings
New York
$617K +$177K +10,200 +44%
Los Angeles Capital Management
63
Los Angeles Capital Management
California
$577K +$87.5K +5,050 +19%
Wells Fargo
64
Wells Fargo
California
$513K +$49.6K +2,862 +12%
Manulife (Manufacturers Life Insurance)
65
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$489K +$173 +10 +0%
State of Wisconsin Investment Board
66
State of Wisconsin Investment Board
Wisconsin
$462K
Bank of America
67
Bank of America
North Carolina
$437K +$125K +7,216 +44%
ProShare Advisors
68
ProShare Advisors
Maryland
$426K +$37.2K +2,145 +10%
GH
69
GAM Holding
Switzerland
$418K
AIG
70
American International Group
New York
$412K +$28.9K +1,668 +8%
MLICM
71
Metropolitan Life Insurance Company (MetLife)
New York
$411K
Tudor Investment Corp
72
Tudor Investment Corp
Connecticut
$370K +$347K +20,029 New
JP Morgan Chase
73
JP Morgan Chase
New York
$359K -$13.9K -800 -4%
NFA
74
Nationwide Fund Advisors
Ohio
$347K
VEA
75
Virtus ETF Advisers
New York
$341K +$29.2K +1,688 +10%

MGNX Hedge Fund Activity: Q3 2017 in Review

113 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2017, worth a combined $583M — up 6.3% from $548M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new MGNX positions and 11 closed out — a net gain of 1 holder — while 48 added to existing stakes and 29 trimmed.

The largest buyer was Pinnacle Associates, adding an estimated $4.05M. The largest seller was Fidelity Investments, cutting an estimated $14.5M.

  • 113 institutional investors held MacroGenics (MGNX) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $583M of MacroGenics stock for Q3 2017, up 6.3% quarter-over-quarter.
  • 12 funds opened new MacroGenics positions in Q3 2017 and 11 closed out, a net change of +1 holder.
  • The largest MacroGenics buyer in Q3 2017 was Pinnacle Associates, an estimated $4.05M added.
  • The largest MacroGenics seller in Q3 2017 was Fidelity Investments, an estimated $14.5M sold.

Based on aggregated 13F filings for Q3 2017.